source
- Charles River partners with Ipsen to employ virtual control groups in toxicology studiesCharles River Laboratories and French biopharma Ipsen announced a collaboration to use Charles River’s virtual control group (VCG) database in an upcoming toxicology study. The VCG approach aims t…
- Novo claims 80% share of oral GLP-1 market as rivalry with Lilly intensifiesNovo's CEO Mike Maziar Doustdar said the company leads the oral GLP-1 market, stating the Wegovy pill holds about 80% of prescriptions since its launch in January. Eli Lilly, however, reported tha…